Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Munschauer

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of the International Neuropsychological Society : JINS|September 20, 2006
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)Ralph H B Benedict, Diane Cookfair, Rebecca Gavett, et al.
Journal of Neuroimmunology|May 16, 2006
Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodiesRoseane Santos, Bianca Weinstock-Guttman, Miriam Tamaño-Blanco, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 21, 2015
Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic StrokeZohara Sternberg, Trevor Chichelli, Daniel Sternberg, et al.
Journal of Neuroimmunology|October 18, 2008
Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patientsZohara Sternberg, Kailash Chadha, Alicia Lieberman, et al.
Journal of Neuroimmunology|October 28, 2008
Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patientsBianca Weinstock-Guttman, Kavitha Bhasi, Darlene Badgett, et al.
Archives of Neurology|September 13, 2006
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosisRalph H B Benedict, Jared M Bruce, Michael G Dwyer, et al.
Journal of Clinical and Experimental Neuropsychology|March 17, 2007
Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosisBrett A Parmenter, Robert Zivadinov, Laura Kerenyi, et al.
Archives of Neurology|November 15, 2006
Interferon inhibitory activity in patients with multiple sclerosisKailash Chadha, Bianca Weinstock-Guttman, Robert Zivadinov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Plasma pentosidine: a potential biomarker in the management of multiple sclerosisZohara Sternberg, Cassandra Hennies, Daniel Sternberg, et al.
Atherosclerosis|July 25, 2013
Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral bloodZohara Sternberg, Husam Ghanim, Kristen M Gillotti, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of the International Neuropsychological Society : JINS|September 20, 2006
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)Ralph H B Benedict, Diane Cookfair, Rebecca Gavett, et al.
Journal of Neuroimmunology|May 16, 2006
Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodiesRoseane Santos, Bianca Weinstock-Guttman, Miriam Tamaño-Blanco, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 21, 2015
Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic StrokeZohara Sternberg, Trevor Chichelli, Daniel Sternberg, et al.
Journal of Neuroimmunology|October 18, 2008
Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patientsZohara Sternberg, Kailash Chadha, Alicia Lieberman, et al.
Journal of Neuroimmunology|October 28, 2008
Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patientsBianca Weinstock-Guttman, Kavitha Bhasi, Darlene Badgett, et al.
Archives of Neurology|September 13, 2006
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosisRalph H B Benedict, Jared M Bruce, Michael G Dwyer, et al.
Journal of Clinical and Experimental Neuropsychology|March 17, 2007
Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosisBrett A Parmenter, Robert Zivadinov, Laura Kerenyi, et al.
Archives of Neurology|November 15, 2006
Interferon inhibitory activity in patients with multiple sclerosisKailash Chadha, Bianca Weinstock-Guttman, Robert Zivadinov, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Plasma pentosidine: a potential biomarker in the management of multiple sclerosisZohara Sternberg, Cassandra Hennies, Daniel Sternberg, et al.
Atherosclerosis|July 25, 2013
Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral bloodZohara Sternberg, Husam Ghanim, Kristen M Gillotti, et al.
Pageof 3